XAB05
/ Xenothera
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 12, 2022
A First-in-Human Study With XAB05 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=25 | Completed | Sponsor: Xenothera SAS | Recruiting ➔ Completed
Trial completion • Infectious Disease
April 01, 2022
A First-in-Human Study With XAB05 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=35 | Recruiting | Sponsor: Xenothera SAS
New P1 trial • Infectious Disease
1 to 2
Of
2
Go to page
1